Exclusive

Publication

Byline

Alebund receives FDA clearance to advance first-in-class AP308 into IgA nephropathy trial

Singapore, Sept. 9 -- Alebund Pharmaceuticals has received clearance from the US Food and Drug Administration for the Investigational New Drug application of AP308, a first-in-class engineered recombi... Read More


Kelun-Biotech partner advances ultra-long-acting asthma antibody into Phase III

Singapore, Sept. 9 -- Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting monoclonal antibody targeting thymic stromal lymphopoietin, a... Read More


Accro and Fosun advance oral TYK2/JAK1 inhibitor AC-201 into China Phase II/III vitiligo trial

Singapore, Sept. 9 -- Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-segmental vitiligo following regulatory clearance from the N... Read More


Abbott partners with Sengkang General Hospital to advance early detection of muscle loss in Singapore

Singapore, Sept. 9 -- Abbott and Sengkang General Hospital (SKH) have announced a new three-year collaboration to expand muscle health screening, training and public education efforts across Singapore... Read More


Japan's Hodogaya Chemical sets up Nucleic Acid CDMO subsidiary

Singapore, Sept. 9 -- Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO business. In its Mid-term Management Plan "CODE/CHORD 2030,", the company... Read More


Korea Advanced Institute of Science and Technology inks partnership with Thermo Fisher

Singapore, Sept. 9 -- Korea Advanced Institute of Science and Technology (KAIST) has partnered with Thermo Fisher Scientific to establish SHARE Hub, a next-generation autonomous research hub where AI ... Read More


Taiwan's Horien achieves three Thai FDA Class 4 approvals and secures US patent for Biodegradable Ureteral Stent

Singapore, Sept. 8 -- Taiwan-based Horien Biochemical Technology has announced a major double milestone in its global expansion strategy, i.e. the formal entry into the Thai market following Thai Food... Read More


Japanese pharma firm Shionogi receives marketing approval in Australia for antibiotic Cefiderocol

Singapore, Sept. 8 -- Japan-based Shionogi has received marketing authorisation from the Therapeutic Goods Administration (TGA) in Australia for cefiderocol, a siderophore cephalosporin developed by S... Read More


Singapore strengthens clinical trials capacity in collaboration with WHO

Singapore, Sept. 8 -- Based at the Saw Swee Hock School of Public Health, National University of Singapore, ADVANCE-ID is Singapore's 13th World Health Organisation (WHO) collaborating centre and join... Read More


Korea's Classys' brings advanced aesthetics and dermatology treatment technology to India in collaboration with Photonence

Singapore, Sept. 8 -- South Korea-based Classys, a global player in medical aesthetics, has stepped into India, through its partnership with Photonence, with a new treatment approach that pairs two of... Read More